Email me when Catalyst4, Inc. files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MPLT | MapLight Therapeutics, Inc. | Common Stock, $0.0001 par value per share | 45.1% | $362M | 19.7M | Catalyst4, Inc. | Oct 28, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|